BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16826361)

  • 1. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
    Rades D; Schild SE
    Strahlenther Onkol; 2006 Jul; 182(7):415-8. PubMed ID: 16826361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
    Rades D; Schild SE
    Cancer; 2006 Mar; 106(5):1140-3. PubMed ID: 16400638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the best available treatment for neurocytomas in children.
    Rades D; Schild SE; Fehlauer F
    Cancer; 2004 Dec; 101(11):2629-32. PubMed ID: 15494975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of atypical neurocytomas.
    Rades D; Fehlauer F; Schild SE
    Cancer; 2004 Feb; 100(4):814-7. PubMed ID: 14770439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
    Rades D; Fehlauer F; Ikezaki K; Schild SE
    Radiother Oncol; 2005 Jan; 74(1):67-9. PubMed ID: 15683672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
    Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
    Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-differentiated neurocytoma: what is the best available treatment?
    Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
    Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of meningeal melanocytomas.
    Rades D; Schild SE; Tatagiba M; Molina HA; Alberti W
    Cancer; 2004 Jun; 100(11):2442-7. PubMed ID: 15160350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the optimal dose of radiation after incomplete resection of central neurocytomas.
    Rades D; Schild SE; Ikezaki K; Fehlauer F
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):373-7. PubMed ID: 12527050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment recommendations for the various subgroups of neurocytomas.
    Rades D; Schild SE
    J Neurooncol; 2006 May; 77(3):305-9. PubMed ID: 16575540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
    Rades D; Haatanen T; Schild SE; Dunst J
    Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
    Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent central neurocytomas.
    Bertalanffy A; Roessler K; Koperek O; Gelpi E; Prayer D; Knosp E
    Cancer; 2005 Jul; 104(1):135-42. PubMed ID: 15880432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neurocytomas express photoreceptor differentiation.
    Mena H; Morrison AL; Jones RV; Gyure KA
    Cancer; 2001 Jan; 91(1):136-43. PubMed ID: 11148570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
    Chen YD; Li WB; Feng J; Qiu XG
    Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.
    Conter C; Carrie C; Bernier V; Geoffray A; Pagnier A; Gentet JC; Lellouch-Tubiana A; Chabaud S; Frappaz D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1536-42. PubMed ID: 19362789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.